Laurus Labs Limited
LAURUSLABS
Classificação em ações
#1760
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Preço da ação
$22.61
Valor de mercado
$12.22B
Variação (1 dia)
-0.96%
Variação (1 ano)
115.45%
País
IN
Negociar Laurus Labs Limited (LAURUSLABS)
Categoria
Healthcare
Receita da Laurus Labs Limited (LAURUSLABS)
Receita em Jun 2026 TTM: $802.27M
De acordo com os últimos relatórios financeiros da Laurus Labs Limited, a receita atual da empresa (TTM) é $802.27M. Em 2024, a empresa obteve uma receita de $604.54M uma diminuição em relação a a receita do ano 2023, que foi de $735.03M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Laurus Labs Limited de 2013 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $802.27M | 23.54% |
| 2025 | $649.39M | 7.42% |
| 2024 | $604.54M | -17.75% |
| 2023 | $735.03M | 13.05% |
| 2022 | $650.19M | -1.12% |
| 2021 | $657.55M | 74.93% |
| 2020 | $375.88M | 13.88% |
| 2019 | $330.06M | 4.51% |
| 2018 | $315.80M | 7.52% |
| 2017 | $293.70M | 9.46% |
| 2016 | $268.31M | 26.21% |
| 2015 | $212.60M | -3.94% |
| 2014 | $221.32M | 67.37% |
| 2013 | $132.24M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 724.12% |
IN
|
